Less Ads, More Data, More Tools Register for FREE

Pin to quick picksME Group Regulatory News (MEGP)

Share Price Information for ME Group (MEGP)

Share Price is delayed by 15 minutes
Get Live Data
100.20    -7.80 (-7.22%)
Bid:
100.80
Ask:
101.60
Spread: 0.80 (0.794%)
Market Cap: £377.06m
MEGP Live PriceLast checked at - London Stock Exchange

Intraday ME Group Share Chart

Form 8.3 - ME Group International Plc

29 Sep 2025 13:42

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

Montanaro Asset Management Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

ME Group International plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

26/09/2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

NO

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

10p Ordinary Shares

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

5,343,176

1.41

(2) Cash-settled derivatives:

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

5,343,176

1.41

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

0.5p Ordinary

Sale

29,100

1.848854

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

29/09/2025

Contact name:

Matthew Francis

Telephone number*:

0207 448 8600

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250929116077/en/

Copyright Business Wire 2025

Date   Source Headline
28th Feb 20254:07 pmRNSHolding(s) in Company
28th Feb 20257:00 amRNSResult of secondary placing in ME Group
27th Feb 20254:36 pmRNSProposed secondary placing in ME Group
27th Feb 20253:45 pmRNSHolding(s) in Company
24th Feb 20257:00 amRNSAnnual Results and Publication of Annual Report
19th Feb 20257:00 amRNS-RNotice of Investor Presentation
3rd Feb 202510:00 amRNSBlock Listing Six Monthly Return
31st Jan 202512:18 pmRNSHolding(s) in Company
22nd Jan 20257:00 amRNSNotice of Results
20th Jan 20257:00 amRNS-RPartnership extension with Morrisons Supermarket
31st Dec 202411:48 amRNSBlock Listing Six Monthly Return
4th Dec 20247:00 amRNSYear-end Trading Update
3rd Dec 20246:05 pmRNSBoard Change
2nd Dec 20247:00 amRNSVoting Rights and Capital
21st Nov 20247:00 amRNSNotice of Trading Update
6th Nov 20244:04 pmRNSDirectorate Change
1st Nov 20247:00 amRNSVoting Rights and Capital
1st Oct 20247:00 amRNSVoting Rights and Capital
12th Sep 20244:12 pmRNSHolding(s) in Company
2nd Sep 20247:00 amRNSVoting Rights and Capital
1st Aug 20247:00 amRNSVoting Rights and Capital
23rd Jul 20241:50 pmRNSPDMR Dealing
15th Jul 20244:23 pmRNSInterim Results - Replacement
15th Jul 20247:03 amRNSInterim Results
1st Jul 20247:00 amRNSVoting Rights and Capital
26th Jun 20247:00 amRNSNotice of Interim Results
10th Jun 20247:00 amRNSTrading Update
4th Jun 20247:00 amRNSNotice of Trading Update
3rd Jun 20247:00 amRNSVoting Rights and Capital
22nd May 20247:00 amRNSDisposal of SEMPA SAS
10th May 20244:49 pmRNSPDMR Dealing
1st May 20247:00 amRNSVoting Rights and Capital
29th Apr 20245:54 pmRNSPDMR Dealing and Issue of Equity - Replacement
26th Apr 20245:33 pmRNSResult of AGM
24th Apr 20245:14 pmRNSPDMR Dealing and Issue of Equity
1st Mar 20247:00 amRNSVoting Capital and Rights
28th Feb 20246:04 pmRNSPublication of Annual Report and Accounts
22nd Feb 20247:00 amRNSPreliminary Results
21st Feb 20244:44 pmRNSTransaction in Own Shares and Total Voting Rights
21st Feb 202410:49 amRNSTransaction in Own Shares and Total Voting Rights
20th Feb 20247:20 amRNSNotice of Investor Presentation
19th Feb 20245:37 pmRNSTransaction in Own Shares and Total Voting Rights
16th Feb 20245:06 pmRNSTransaction in Own Shares and Total Voting Rights
15th Feb 20244:37 pmRNSTransaction in Own Shares and Total Voting Rights
14th Feb 20244:55 pmRNSTransaction in Own Shares and Total Voting Rights
13th Feb 20245:33 pmRNSTransaction in Own Shares and Total Voting Rights
8th Feb 20245:15 pmRNSTransaction in Own Shares and Total Voting Rights
7th Feb 20245:59 pmRNSTransaction in Own Shares and Total Voting Rights
6th Feb 20246:24 pmRNSTransaction in Own Shares and Total Voting Rights
5th Feb 20244:55 pmRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.